C65.2 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of left renal pelvis. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Malignant tumor of renal pelvis
- Primary malignant neoplasm of left renal pelvis
- Primary malignant neoplasm of renal pelvis
- Transitional cell carcinoma of kidney
- Transitional cell carcinoma of left kidney
- Transitional cell carcinoma of left renal pelvis
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|C65.2||189.1 - Malig neo renal pelvis|
|Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.|
You have two kidneys. They are fist-sized organs on either side of your backbone above your waist. The tubes inside filter and clean your blood, taking out waste products and making urine. Kidney cancer forms in the lining of tiny tubes inside your kidneys.
Kidney cancer becomes more likely as you age. Risk factors include smoking, having certain genetic conditions, and misusing pain medicines for a long time.
You may have no symptoms at first. They may appear as the cancer grows. See your health care provider if you notice:
- Blood in your urine
- A lump in your abdomen
- Weight loss for no reason
- Pain in your side that does not go away
- Loss of appetite
Tests to diagnose kidney cancer include blood, urine, and imaging tests. You may also have a biopsy.
Treatment depends on your age, your overall health and how advanced the cancer is. It might include surgery, chemotherapy, or radiation, biologic, or targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)